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Introduction
Tumor Necrosis Factor Receptor (TNFR) Associated Peri-
odic Syndrome (TRAPS) is a dominant autoinflammatory
disorder caused by heterozygous mutations in TNFRSF1A,
the gene encoding the TNFalpha receptor 1 (TNFR1).
TNFRSF1A mutations induce aberrant localization and
accumulation in aggregates of the mutant TNFR1 pro-
teins, elevated levels of reactive oxygen species (ROS) and
excessive inflammatory response. In accordance to the
emerging role of autophagy in inflammatory response, we
have recently demonstrated that mutant TNFR1 accumu-
lation is due to a defective autophagy function, the main
cellular mechanism involved in the elimination of cellular
inclusions containing mutant proteins.
Objectives
Investigation of the role of autophagy in TRAPS and
search for drugs able to counteract mutant TNFR1mu-
tant accumulation by autophagy induction.
Methods
To search a link between TNFRSF1A mutations and
inflammation in TRAPS, by means of both in vitro and
ex vivo systems, represented by HEK293T cells trans-
fected with expression constructs for WT and mutant
TNFR1 proteins and by monocytes, derived by TRAPS
patients, respectively, we have investigated the cellular
response to mutant TNFR1 proteins in terms of autop-
hagy efficiency, NF-kB activity and mutant TNFR1 loca-
lization after drugs treatments.
Results
We have found that autophagy is the main mechanism
involved in mutant TNFR1 elimination and that it is
impaired in the presence of misfolded proteins, thus
likely accounting for their accumulation. This compel-
lingly accounts for TRAPS associated induction of
NF-kB activity, as well as excessive IL-1b secretion and
chronic inflammation.
We also show that autophagy inhibition due to TNFR1
mutant proteins can be reverted, as demonstrated by the
effects of the antibiotic geldanamycin found to rescue
membrane localization of mutant TNFR1 proteins, to
reduce their aggregation and to counteract the enhanced
inflammation by decreasing IL-1b secretion.
Conclusion
Overall, these observations provide a rationale to the
apparent paradox that so far the most effective therapy
in TRAPS is represented by inhibition of the cascade
signaling induced by IL-1b rather than by the use of
drugs counteracting the TNFR1-mediated pathway;
therefore, we propose autophagy as a novel therapeutic
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